MedPath

The Effect of Sodium Alginate on Appetite Sensation

Phase 1
Completed
Conditions
Overweight
Obesity
Interventions
Dietary Supplement: Alginate
Dietary Supplement: Placebo
Registration Number
NCT01101633
Lead Sponsor
University of Copenhagen
Brief Summary

The aim of the study is to investigate the effects of a low-calorie alginate containing fruit flavored beverage on appetite and body weight development.

Detailed Description

The project consists of two different studies:

Study I: A randomised controled meal test study aimed at studying the acute effect of the alginate-containing beverage on appetite sensation and spontaneous calorie intake (and safety i.e. nausea, well-being etc) in normal to overweight healthy subjects. Here, a placebo beverage or the alginate-containing beverage will be administered as a pre-load before a standardised breakfast meal. Subjective appetite sensation will be measured with Visual Analogue Scale (VAS) every 30 minutes four up to 5 hours. An additional beverage will be administered prior to an ad libitum lunch meal, where spontaneous water and energy intake will be registered.

Study II: Secondly the aim is to study the effects of a daily intake of a placebo or alginate-containing beverage on body weight and composition in a randomised parallel intervention study of 12 weeks duration. A total of app. 50 obese healthy adults will receive a hypocaloric diet and be randomised to consume either placebo or alginate-containing beverage before each of the three main meals every day. The development in body weight and composition and blood pressure will be monitored and blood samples will be analysed for markers related to the risk of CVD and type 2 diabetes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Healthy men and women
  • Normal to slight overweight (BMI: 22-28 kg/m2)
  • 20-45 years of age
Exclusion Criteria
  • Smoking
  • Daily medicine use (oral contraceptives excluded)
  • Use of dietary supplements
  • Blood donation 3 months prior to the study
  • Hb<7.5 mmol/l
  • Chronic illnesses such as hyperlipidemia, diabetes and inflammatory diseases
  • Pregnancy or breastfeeding
  • Elite athletes (>10 hours hard exercise/week)
  • Vegetarians

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1Alginate500 ml beverage containing alginate (3%)
3Placebo500 ml beverage without alginate (placebo)
4Placebo330 ml beverage without alginate (placebo)
2Alginate330 ml beverage containing alginate (3%)
Primary Outcome Measures
NameTimeMethod
appetite sensation5 hours
Secondary Outcome Measures
NameTimeMethod
Plasma insulin and glucose level5 hours
Well being and adverse events5 hours
spontaneous calorie intake5 hours
gastric emptying5 hours

Trial Locations

Locations (1)

Department of Human Nutrtion, University of Copenhagen

🇩🇰

Frederiksberg, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath